← Open Payments lookup

SUSAN ESSING-SPILLER: Open Payments

NPI 1548612344 · NEW ALBANY, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,474 in 121 payments from 43 companies in 2025. Trend: 2023 $0 · 2024 $22 · 2025 $2,474

Food & beverage: $2,374Education: $100
CompanyPaymentsAmount
Novartis Pharmaceuticals Corporation13$254
Incyte Corporation6$214
ABBVIE INC.11$209
AstraZeneca Pharmaceuticals LP6$139
PharmaEssentia USA Corporation5$101
TerSera Therapeutics LLC4$100
Takeda Pharmaceuticals U.S.A., Inc.5$97
Janssen Biotech, Inc.5$94
E.R. Squibb & Sons, L.L.C.5$92
Merck Sharp & Dohme LLC5$88

Products named: VENCLEXTA, Fabhalta, KISQALI, BESREMI, OPDIVO, KEYTRUDA, XTANDI, RYTELO.

Industry payments across IN — which companies pay providers there.